Yerram is a urologic oncologist at Hackensack University Medical Center in New Jersey.
Nitin Yerram, MD, on a liquid biopsy urine test for prostate cancer
The miR Sentinel Prostate Cancer Test is a standalone liquid biopsy urine test.
Nitin Yerram, MD, highlights trial of 177Lu-PSMA-617 in localized prostate cancer
The PRELUDE trial is assessing oncological outcomes with neoadjuvant 177Lu-PSMA-617 in high-risk, localized prostate cancer.
Nitin Yerram, MD, highlights new resource center for patients with renal cell carcinoma
The website is meant to educate patients and their caregivers on several aspects of the kidney cancer journey.
FDA grants breakthrough device designation for ArteraAI Prostate tool
Data supports combination intravesical chemotherapy for high-risk NMIBC
EMBARK: Significant OS gains seen with enzalutamide plus leuprolide in nmHSPC
FDA grants fast track designation to TRE-515 with 177Lu-PSMA-617 for mCRPC